Back Dictionary Export CSV
Filter: Clear
MERGED_REGIMEN_ID MERGED_TUMOUR_ID HEIGHT_AT_START_OF_REGIMEN WEIGHT_AT_START_OF_REGIMEN INTENT_OF_TREATMENT DATE_DECISION_TO_TREAT START_DATE_OF_REGIMEN MAPPED_REGIMEN CLINICAL_TRIAL CHEMO_RADIATION MERGED_PATIENT_ID BENCHMARK_GROUP
220015087 220021034 1.64 60 Palliative (P) 2014-09-15 2014-09-18 DABRAFENIB + TRAMETINIB N N 220022881 MITOXANTRONE + TRETINOIN
220015088 220009745 1.7 112 Curative (C) 2016-08-26 2016-10-07 Carboplatin AUC 6 - 10 N N 220022925 VINCRISTINE
220015089 220009746 1.39 81 Curative (C) 2013-10-23 2013-10-25 CHOP R - 21 days N N 220023120 BUSULFAN + CYCLOPHOSPHAMIDE
220015090 220009747 1.64 67.3 null 2015-05-06 2015-05-06 Carboplatin AUC 6 - 10 null null 220023457 CAPECITABINE
220015091 220009748 null 103 null 2013-04-13 2013-05-28 CTD 99 N 220023457 BENDAMUSTINE + RITUXIMAB
220015092 220009749 null null null 2016-05-21 2016-06-02 CISPLATIN + RT N N 220023979 MELPHALAN
220015093 220009751 1.66 65.8 Curative (C) 2014-08-02 2014-08-03 PEMBROLIZUMAB N N 220024165 SUNITINIB
220015094 220009752 null 84.3 null 2017-02-14 2017-06-23 Carboplatin AUC 2 - 5 null null 220025308 ARSENIC TRIOXIDE
220015095 220009752 1.68 77 Curative (C) 2014-07-06 2014-07-06 CYTARABINE + FLUDARABINE + IDARUBICIN null N 220025308 CYTARABINE + METHOTREXATE
220015096 220009754 1.52 89 Curative (C) 2019-07-26 2019-08-03 Carboplatin AUC 2 - 5 N N 220026026 DABRAFENIB
220015097 220009755 1.67 69.1 Curative (C) 2018-10-05 2018-10-20 CAPECITABINE + OXALIPLATIN N N 220026216 ARSENIC TRIOXIDE + ATRA
220015098 220009757 1.69 73.8 Curative (C) 2016-05-30 2016-05-30 FIGARO TRIAL N N 220026351 ALEMTUZUMAB + CYCLOPHOSPHAMIDE
220015099 220009758 1.65 0 Curative (C) 2017-04-10 2017-04-10 Cisplatin + Radiotherapy 01 N 220026615 MERCAPTOPURINE
220015100 220009758 null null Disease modification (D) null 2018-04-12 FLUDARABINE null null 220026615 MELPHALAN
220015101 220009758 1.82 166.7 Curative (C) 2018-04-13 2018-09-03 IPILIMUMAB + NIVOLUMAB N N 220026615 DABRAFENIB
220015102 220015139 1.69 58.5 Palliative (P) 2017-11-13 2017-11-27 Cytarabine+Methotrexate Intrathecal 2 N 220027021 IPILIMUMAB + NIVOLUMAB
220015103 220009760 1.77 68 Disease modification (D) 2018-10-08 2018-10-23 EOX 02 N 220027094 ETOPOSIDE
220015104 220009761 1.7 91.7 Disease modification (D) null 2018-07-18 Etoposide IV 2 N 220027282 CLADRIBINE
220015105 220015140 1.76 57.6 Curative (C) 2017-01-22 2017-01-31 Arsenic trioxide N N 220027282 CAPECITABINE + OXALIPLATIN
220015106 220009762 1.72 0 Palliative (P) 2016-05-03 2016-07-11 LENALIDOMIDE N N 220027500 UKALL2011
220015107 220009763 1.8 null Curative (C) 2015-08-22 2015-12-08 Alemtuzumab+Busulfan+CyclophosphMUD null null 220027517 CAPECITABINE
220015108 220009764 1.64 76 Curative (C) 2017-02-19 2017-03-06 Y-90 2 N 220027666 MIDAC
220015109 220009766 null null Curative (C) 2014-09-08 2014-09-27 Carboplatin + Cetux + FU (>Cycle 2) N N 220027883 EOX
220015110 220015142 1.86 81.2 Curative (C) 2018-04-22 2018-07-01 Doxorubicin + Ifosfamide N N 220027990 CETUXIMAB + IRINOTECAN + MDG
220015111 220015142 null null Curative (C) 2018-07-11 2018-07-11 Busulfan po + Fludarabine RIC Allo N N 220027990 CAV
220015112 220009767 1.54 80.5 Palliative (P) 2018-05-15 2018-05-28 IPILIMUMAB + NIVOLUMAB 02 N 220028561 CYCLOPHOSPHAMIDE HIGH DOSE
220015113 220015143 1.7 82.5 Curative (C) null 2015-11-17 CISPLATIN + RT N N 220028611 CYTARABINE + IDARUBICIN
220015114 220009768 1.79 119.4 null 2015-05-24 2015-08-18 MELPHALAN null null 220028693 ARSENIC TRIOXIDE
220015115 220009768 1.75 23.8 Curative (C) 2016-12-22 2016-12-22 PERM Trial 02 N 220028693 CYTARABINE + IDARUBICIN
220015116 220020013 1.57 67.3 null 2018-02-27 2018-03-19 CETUXIMAB 02 N 220028838 EOX
220015117 220009769 0 82 null 2018-01-21 2018-02-28 LIPOSOMAL DOXORUBICIN N null 220029019 CARBOPLATIN
220015118 220015145 1.67 44.8 Palliative (P) 2016-11-13 2016-12-05 Ipilimumab 02 N 220029097 GCLAC
220015120 220009771 1.62 80.6 Disease modification (D) 2014-09-17 2014-10-09 Abiraterone 2 N 220029136 FIGARO TRIAL
220015121 220009772 1.7 null null 2018-02-23 2018-02-23 Capecitabine (21days) + Carboplatin N N 220029150 CARBOPLATIN + CETUXIMAB + FU
220015122 220009772 1.63 60 Curative (C) 2018-02-24 2018-02-26 Eribulin N N 220029150 SORAFENIB
220015123 220009772 null 83.6 null 2019-02-06 2019-03-16 MELPHALAN N N 220029150 MITOXANTRONE + TRETINOIN
220015124 220009775 null 116.3 null 2017-04-14 2017-04-27 Methotrexate High Dose (3g/m2) N N 220029686 CISPLATIN + DOCETAXEL + FLUOROURACIL
220015125 220015149 1.55 68.3 Neo-adjuvant (N) null 2014-12-08 Capecitabine + Oxaliplatin 21day 02 N 220029875 IPILIMUMAB + NIVOLUMAB
220015126 220015149 1.84 89 Palliative (P) 2015-10-01 2015-10-01 BUSULFAN + CYCLO 02 N 220029875 RAVVA TRIAL
220015127 220015149 1.58 72.8 Palliative (P) 2018-04-05 2018-04-05 Trifluridine + Tipiracil N N 220029875 IPILIMUMAB
220015128 220009777 1.63 null null 2014-07-03 2017-11-07 Capecitabine + Oxaliplatin 21day N N 220031025 METHOTREXATE HIGH DOSE
220015129 220015150 1.68 61.4 null 2013-07-29 2014-01-17 LIPOSOMAL DOXORUBICIN 2 Y 220031025 TEMOZOLOMIDE + RT
220015130 220020016 1.83 86.5 Curative (C) 2017-03-29 2017-04-09 CAMELLIA Trial N N 220031271 CISPLATIN + ETOPOSIDE
220015131 220009778 null 30.05 Neo-adjuvant (N) 2017-05-04 2017-05-05 CVAD null N 220031497 ALEMTUZUMAB + CYCLOPHOSPHAMIDE
220015132 220009780 1.73 23.7 Palliative (P) 2014-07-15 2014-07-15 Y-90 N N 220031627 MERCAPTOPURINE
220015133 220009781 null 65.099 Palliative (P) 2017-04-20 2017-05-09 Bendamustine + prednisolone N N 220031627 CARBOPLATIN
220015134 220009784 1.78 92 null 2018-04-30 2018-05-28 Pazopanib 2 N 220032395 RALTITREXED
220015135 220009787 1.64 79.7 Curative (C) 2016-04-04 2016-04-04 PEMBROLIZUMAB N Y 220032395 ALEMTUZUMAB + BUSULFAN + CYCLOPHOSPHAMIDE
220015136 220009789 null 65.7 Palliative (P) 2016-12-19 2017-06-08 Capecitabine + Oxaliplatin 21day 02 N 220033190 PAZOPANIB
220015137 220009789 1.64 47.4 null 2015-08-14 2015-08-20 Bevacizumab 7.5mg/kg 2 N 220033190 IPM